1,445
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy

, , , , , , & show all
Article: 2308922 | Received 27 May 2023, Accepted 17 Jan 2024, Published online: 27 Jan 2024

References

  • Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107
  • Cardona-Perez JA, Villegas-Mota I, Helguera-Repetto AC, et al. Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: results from universal screening in a tertiary care center in Mexico city, Mexico. PloS One. 2021;16(4):e0249584. doi: 10.1371/journal.pone.0249584
  • Abedzadeh-Kalahroudi M, Sehat M, Vahedpour Z, et al. Maternal and neonatal outcomes of pregnant patients with COVID-19: a prospective cohort study. Int J Gynaecol Obstet. 2021;153(3):449–9. doi: 10.1002/ijgo.13661
  • Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020;324(17):1782–5. doi: 10.1001/jama.2020.19124
  • Barbero P, Muguerza L, Herraiz I, et al. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. J Matern Fetal Neonatal Med. 2020;35(14):2648–2654. doi: 10.1080/14767058.2020.1793320
  • Brandt JS, Hill J, Reddy A, et al. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2021;224(4):.e389.1–.e389.9. doi: 10.1016/j.ajog.2020.09.043
  • Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021;175(8):817. doi: 10.1001/jamapediatrics.2021.1050
  • Jering KS, Claggett BL, Cunningham JW, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021;181(5):714–7. doi: 10.1001/jamainternmed.2020.9241
  • Papageorghiou AT, Deruelle P, Gunier RB, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021 Sep 1;225(3):289–e1. doi: 10.1016/j.ajog.2021.05.014
  • Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347–1354. doi: 10.15585/mmwr.mm6938e1
  • Lai J, Romero R, Tarca AL, et al. SARS-COV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose response relationship supporting causality. Am J Obstet Gynecol. 2021;225(6):689–693.e1. doi: 10.1016/j.ajog.2021.08.020
  • Wei SQ, Bilodeau-Bertrand M, Liu S, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548. doi: 10.1503/cmaj.202604
  • Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571–80. doi: 10.1097/AOG.0000000000004339
  • Rosenbloom JI, Raghuraman N, Carter EB, et al. Coronavirus disease 2019 infection and hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2021;224(6):623–4. doi: 10.1016/j.ajog.2021.03.001
  • Adhikari EH, Moreno W, Zofkie AC, et al. Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection. JAMA Netw Open. 2020;3(11):e2029256. doi: 10.1001/jamanetworkopen.2020.29256
  • Zhang L, Dong L, Ming L, et al. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China. Bmc Pregnancy Childbirth. 2020;20(1):394. doi: 10.1186/s12884-020-03026-3
  • Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021;225(5):.e522.1–.e522.11. doi: 10.1016/j.ajog.2021.05.016
  • Palmsten K, Vazquez-Benitez G, Kharbanda EO. Point: uncertainty about estimating the risks of COVID-19 during pregnancy. Paediatric Perinatal Epid. 2021;36(4):450–452. doi: 10.1111/ppe.12773
  • Hughes BL, Sandoval GJ, Metz TD, et al. First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes. Am J Obstet Gynecol. 2023 Feb;228(2):.e226.1–.e226.9. do i:
  • Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–87. doi: 10.1093/cvr/cvaa106
  • Shanes ED, Mithal LB, Otero S, et al. Placental pathology in COVID-19. Am J Clin Pathol. 2020;154(1):23–32. doi: 10.1093/ajcp/aqaa089
  • Fabre M, Calvo P, Ruiz-Martinez S, et al. Frequent placental SARS-CoV-2 in patients with COVID-19-associated hypertensive disorders of pregnancy. Fetal Diagn Ther. 2021;48(11–12):801–811. doi: 10.1159/000520179
  • Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG. 2020;127(11):1374–80. doi: 10.1111/1471-0528.16339
  • Rolnik DL. Can COVID-19 in pregnancy cause pre-eclampsia? BJOG. 2020;127(11):1381. doi: 10.1111/1471-0528.16369
  • Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. doi: 10.1016/S0140-6736(20)30628-0
  • Patberg ET, Adams T, Rekawek P, et al. Coronavirus disease 2019 infection and placental histopathology in women delivering at term. Am J Obstet Gynecol. 2021;224(4):.e382.1–.e382.18. doi: 10.1016/j.ajog.2020.10.020
  • Baergen RN, Heller DS. Placental pathology in COVID-19 positive mothers: preliminary findings. Pediatr Dev Pathol. 2020;23(3):177–80. doi: 10.1177/1093526620925569
  • Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260. doi: 10.1097/AOG.0000000000003891
  • Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200. doi: 10.1093/aje/kwi188
  • Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551–61. doi: 10.1002/sim.4780080504
  • Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat. 2016;70(2):129–133. doi: 10.1080/00031305.2016.1154108
  • Sacinti KG, Kalafat E, Sukur YE, et al. Increased incidence of first‐trimester miscarriage during the COVID‐19 pandemic. Ultrasound Obstet Gynecol. 2021;57(6):1013. doi: 10.1002/uog.23655
  • Tong S, Kaur A, Walker SP, et al. Miscarriage risk for asymptomatic women after a normal first-trimester prenatal visit. Obstet Gynecol. 2008;111(3):710–4. doi: 10.1097/AOG.0b013e318163747c
  • Bianchi FP, Stefanizzi P, Di Gioia MC, et al. COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21(10):1443–54. doi: 10.1080/14760584.2022.2100766
  • Getahun D, Peltier MR, Lurvey LD, et al. Association between SARS-CoV-2 infection and adverse perinatal outcomes in a large health maintenance organization. Am J Perinatol. 2022 Jun;41(2):199–207. doi: 10.1055/s-0042-1749666
  • Neelam V, Reeves EL, Woodworth KR, et al. Pregnancy and infant outcomes by trimester of SARS-CoV -2 infection in pregnancy– SET-NET , 22 jurisdictions, January 25, 2020–December 31, 2020. Birth Defects Res. 115(2):145–159. doi: 10.1002/bdr2.2081
  • Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. doi: 10.1136/bmj.l2381
  • Narang K, Enninga EA, Gunaratne MD, et al. SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review. InMayo Clinic Proceedings. 2020 Aug 1;95(8):1750–1765. doi: 10.1016/j.mayocp.2020.05.011
  • Dutta S, Kumar S, Hyett J, et al. Molecular targets of aspirin and prevention of preeclampsia and their potential association with circulating extracellular vesicles during pregnancy. Int J Mol Sci. 2019;20(18):4370. doi: 10.3390/ijms20184370
  • Ford ND, Cox S, Ko JY, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization—United States, 2017–2019. Morbidity Mortality Weekly Rep. 2022;71(17):585. doi: 10.15585/mmwr.mm7117a1
  • Smith ER, Oakley E, Grandner GW, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2022;228(2):161–177. doi: 10.1016/j.ajog.2022.08.038